Printer Friendly

Browse Drug approval topic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha(TM) (evolocumab). Aug 27, 2015 3480
U.S. FDA approves Synjardy (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes. Aug 27, 2015 4512
Pink pill arouses doubts. Aug 26, 2015 513
Dr. Thomas E. Young Now Offering KYBELLA[TM], the First and Only Injectable Drug for Submental Fullness, or Double Chin. Aug 25, 2015 1312
Elsevier's PharmaPendium Bolsters UCL's Research in Drug Repurposing and Personalized Medicine. Aug 24, 2015 902
Elsevier's PharmaPendium Bolsters UCL's Research in Drug Repurposing and Personalized Medicine. Aug 24, 2015 898
Punjab Government approves to establish drug task force across province. Aug 23, 2015 107
Statements non-exclusive discount agreements pursuant to A* 130a para. 8 sgb v as part of the approval procedure for drug formoterol and beclomethasone, atc code r03ak08, during the period from 01.10.2. Aug 22, 2015 132
S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder. Aug 20, 2015 953
Nuvo Research[R] Announces U.S. Patent for Topical Foamed Formulations that Include DMSO. Aug 20, 2015 1435
U.S. FDA approves 'female Viagra' with strong warning. Aug 19, 2015 743
United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million. Aug 19, 2015 627
Lannett Receives FDA Approval, Launches Generic Antidepressant Drug ABILIFY. Aug 18, 2015 615
Sprout Pharmaceuticals Receives FDA Approval Of Addyi(TM) (flibanserin 100 mg). Aug 18, 2015 2054
Even The Score: FDA Approval of First-Ever Medical Treatment Option for HSDD is Game Changer for Women. Aug 18, 2015 1209
Screen well fda approved drug library v2 and 02 more items. Aug 18, 2015 127
Omeros Announces Plan to File Infringement Suit Against ANDA Filer. Aug 17, 2015 1254
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS (fentanyl buccal soluble film) CII. Aug 13, 2015 1874
Integrity Applications Submits Pre-Submission Documents for the GlucoTrack model DF-F to U.S. FDA. Aug 13, 2015 936
Allergan Confirms Generic Noxafil Patent Challenge. Aug 11, 2015 839
FDA Accepts a Supplemental New Drug Application for Review of Brintellix (vortioxetine) Clinical Trial Data That Assessed Cognitive Function in Patients with Major Depressive Disorder. Aug 10, 2015 3434
Upsher-Smith Receives FDA Approval For Generic Version Of Namenda (Memantine HCl) Tablets. Aug 10, 2015 961
Mylan Launches Generic Version of Lidoderm Patch. Aug 10, 2015 614
Flowonix Medical Inc. Announces FDA Approval of New Product. Aug 7, 2015 618
Now, govt to vet all drugs for your pets. Aug 7, 2015 347
Valor Biotherapeutics to Begin Phase 1 Clinical Study of Novel Lymphoma Therapy. Aug 6, 2015 1017
Dr. Shawn Garber Among Handful of Surgeons in the United States with FDA Approved Orbera Gastric Balloon Placement Experience for Non Surgical Weight Loss. Aug 6, 2015 726
Mylan Launches Generic Nexium Delayed-Release Capsules. Aug 5, 2015 634
Par Pharmaceutical Begins Shipment of Generic Sodium Edecrin. Aug 4, 2015 386
Potential FDA Approval of "Pink Viagra" Sends Wrong Message. Aug 4, 2015 866
Disposable Items, Re Usable Items (Fda Approved), Heart Valves And Valved Conduits For The Department Of Ctvs. Aug 4, 2015 129
Omidria Approved for Commercialization Throughout the European Union and Additional Countries. Aug 3, 2015 1070
Mundipharma EDO GmbH Announces FDA Investigational New Drug Approval of its First Anti-Cancer Compound, EDO-S101, for the Treatment of Patients with Relapsed/Refractory Haematologic Malignancies and Solid Tumours. Jul 31, 2015 1153
Mundipharma EDO GmbH Announces FDA Investigational New Drug Approval of its First Anti-Cancer Compound, EDO-S101, for the Treatment of Patients with Relapsed/Refractory Haematologic Malignancies and Solid Tumours. Jul 31, 2015 1159
FDA Approves Bayer's Finacea (azelaic acid) Foam, 15% for the Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea. Jul 31, 2015 1435
HUMIRA (Adalimumab) Approved by European Commission for Moderate to Severe Hidradenitis Suppurativa (HS). Jul 30, 2015 1709
Allergan Confirms Generic Tyvaso Patent Challenge. Jul 30, 2015 909
Breckenridge Announces Approval for Azelastine HCl Nasal Solution (Nasal Spray). Jul 29, 2015 290
Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders. Jul 29, 2015 581
New FDA-Approved KYBELLA(TM) -- First and Only Injectable Drug for "Double Chin". Jul 27, 2015 648
FDA Approves Kyprolis (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma. Jul 24, 2015 3707
Bristol-Myers wins approval for 1st hepatitis C type 3 drug. Jul 24, 2015 108
IGI Laboratories, Inc. Announces Sixth ANDA Submission Of 2015. Jul 23, 2015 521
European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha(TM) (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol. Jul 21, 2015 3317
European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha(TM) (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol. Jul 21, 2015 3353
SAPHRIS (asenapine) 2.5 mg Sublingual Tablets for the Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder in Pediatric Patients (ages 10-17) Now Available in Pharmacies throughout the U.S. Jul 17, 2015 2155
GSK begins shipping 2015-16 US flu vaccines with focus on customer needs, volume, and speed. Jul 16, 2015 2301
Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders. Jul 16, 2015 1344
Mylan One of First to Launch Generic Version of Namenda Tablets. Jul 14, 2015 418
Systems Biology Group, International Center for Integrative Systems: GMO Soy Accumulates Formaldehyde & Disrupts Plant Metabolism, Suggests Peer-Reviewed Study, Calling For 21st Century Safety Standards. Jul 14, 2015 693
Aquila Solutions, LLC Partners with Evofem, Inc. to Submit New Drug Application to U.S. FDA for Amphora as a Contraceptive. Jul 13, 2015 311
The Raleigh Clinic For Men Makes Life After Prostate Cancer Less Uncertain, More Fulfilling with Effective and FDA-approved ED Solution. Jul 13, 2015 728
IMBRUVICA (ibrutinib) Now Approved to Treat Waldenstrom's Macroglobulinemia in Europe. Jul 10, 2015 2749
Veloxis Announces U.S. FDA Approval of Envarsus XR for Treatment of Kidney Transplant Patients. Jul 10, 2015 1378
PAREXEL Expands Model-Based Drug Development Offering. Jul 9, 2015 1085
IGI Laboratories, Inc. Announces FDA Approval And Commercial Launch Of Diclofenac Sodium, 1.5%. Jul 9, 2015 665
Diclegis for Morning Sickness Now Available Through Wisconsin Fee-For-Service Medicaid Program. Medical condition overview Jul 9, 2015 1357
Diclegis for Morning Sickness Now Available Without Prior Authorization Through Connecticut Fee-For-Service Medicaid Program. Medical condition overview Jul 9, 2015 1316
Diclegis for Morning Sickness Now Available Through Humana Pharmacy Solutions. Medical condition overview Jul 9, 2015 1462
Lilly Statement on FDA Advisory Committee Review of Necitumumab. Jul 9, 2015 1091
Protein Sciences Receives Approval from FDA for 2015/16 Formulation of Flublok Influenza Vaccine. Jul 8, 2015 942
HETLIOZ Receives European Commission Approval for the Treatment of Non-24-Hour Sleep-Wake Disorder in the Totally Blind. Jul 7, 2015 1322
New delay in decision on pioneering drug. Jul 4, 2015 697
Frustration as drug decision is delayed. Jul 4, 2015 539
Gummy-Tip Announces a Tentative Release Date of September 21, 2015 for Its Newest Product, Pending FDA Approval, the Gummy-Tip Condom. Jul 3, 2015 713
Galderma Receives FDA Approval to Market Restylane Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area. Jul 2, 2015 1211
Physician certification recommended for flibanserin: drug would be first approval for hyposexual desire disorder in premenopausal women. Mechcatie, Elizabeth Jul 1, 2015 731
FDA decision on flibanserin expected by August. Mechcatie, Elizabeth Jul 1, 2015 702
Dearth of high-quality research. Jul 1, 2015 207
FDA panel backs flibanserin for sexual disorder. Mechcatie, Elizabeth Jul 1, 2015 828
FDA advisers urge physician certification for flibanserin: the panel supports approval 'only if' risk management options are implemented. Mechcatie, Elizabeth Jul 1, 2015 1391
PERU DRUG MULE GIRL HOME 'WITHIN WEEKS' Judge approves move to UK jail. Jun 29, 2015 429
Parenteral Drug Association Education approved by N.J. Engineering Board as CPC Provider. Jun 29, 2015 314
SIMPONI Receives European Commission Approval for Treatment of Non-radiographic Axial Spondyloarthritis. Jun 26, 2015 3622
SIMPONI Receives European Commission Approval for Treatment of Non-radiographic Axial Spondyloarthritis. Jun 26, 2015 3618
MM-398 Receiving the Priority Review Designation by US FDA for New Drug Application and the Acceptance of Market Authorization Application by EMA in Post-Gemcitabine Metastatic Pancreatic Cancer. Jun 25, 2015 621
Boston Healthcare Report Describes How Understanding of the Therapeutic Value of Cancer Drugs Increases after Initial FDA Approval. Jun 23, 2015 616
DrugsUP: Solute carrier proteins and the uptake of cytotoxic approved drugs. Jun 23, 2015 348
Eisai Announces FDA Approval of FYCOMPA (perampanel) CIII for Adjunctive Therapy in the Treatment of Primary Generalized Tonic-Clonic Seizures in Patients with Epilepsy Age 12 and Older. Jun 22, 2015 2282
U.S. FDA Approves Eisai's Antiepileptic Agent Fycompa as Adjunctive Treatment For Primary Generalized Tonic-Clonic Seizures. Jun 22, 2015 1366
75 veterinary drugs approved by ministry. Jun 21, 2015 394
New cancer drug approved. Jun 21, 2015 409
Sanofi Pasteur MSD : GARDASIL9: New HPV Vaccine Approved in the European Union. Jun 17, 2015 560
Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve. Jun 17, 2015 850
FDA Approves ZOMIG (zolmitriptan) Nasal Spray for Migraine in Pediatric Patients (Ages 12-17). Jun 16, 2015 2217
Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR(TM) PMA Approval. Jun 16, 2015 603
Chiasma Submits New Drug Application to U.S. FDA for Octreotide Capsules in Acromegaly. Jun 15, 2015 828
Doctors Would Have 18% of High-Cholesterol Patients take New PCSK9 Inhibitor Drugs Today If FDA Approves Their Use, According to New Data from InCrowd. Jun 12, 2015 1027
Reaction Biology Receives NIH Grant Award For Bromodomain Research. Jun 12, 2015 543
Update on Zofran Birth Defects Class Action From Bonsignore Trial Lawyers. Jun 12, 2015 591
Ahead of Supreme Court Decision on the Future of Healthcare Subsidies, Prescription Hope Prepared to Help. Jun 11, 2015 648
Novartis gains FDA approval for Promacta providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder. Jun 11, 2015 3414
Novartis presents new data at WCD that shows significant efficacy of Cosentyx in patients with psoriasis of the palms, soles of feet and nails. Jun 11, 2015 2517
Amgen To Discuss Details Of Repatha(TM) (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol. Jun 10, 2015 2680
Lyophilization Services of New England Completes Successful FDA Pre-Approval Inspection For Sterile Drug Product. Jun 9, 2015 509
Conditional approval for Hepatitis C drug. Jun 5, 2015 471
U.S. FDA panel backs female libido drug, with conditions. Jun 5, 2015 553
S1 Biopharma Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder. Jun 5, 2015 391
Even The Score Applauds FDA Advisory Committee as it Makes #HERstory by Recommending Approval of First-Ever Medical Treatment for Women's Most Common Sexual Dysfunction. Jun 4, 2015 907
FDA Advisory Committee Recommends Approval for Sprout Pharmaceuticals' ADDYI(TM) (flibanserin) to Treat Hypoactive Sexual Desire Disorder in Premenopausal Women. Jun 4, 2015 904
Palatin Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder. Jun 4, 2015 330
Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone. Jun 3, 2015 873
PS957m plan for RURALWALEs will help our farmers close the gap; After the European Commission formally approved the Welsh Government's Rural Development Programme, Deputy Minister for Farming and Food, Rebecca Evans, explains why it was a good week for Wales. Jun 2, 2015 781
The European Commission Approves Helsinn's Akynzeo (netupitant/palonosetron) for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in the European Union. Jun 2, 2015 1545
The European Commission Approves Helsinn's Akynzeo (netupitant/palonosetron) for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in the European Union. Jun 2, 2015 1549
Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex D Tablets. Jun 2, 2015 1259
(ph no.:31105) elastic stockings (above knee) fda approved xl size. Jun 2, 2015 116
FDA Approves Expanded Indication For Qudexy XR (Topiramate) Extended-Release Capsules Within The Pediatric Population. Jun 1, 2015 2288
George Zorich to UW Pharm Grads--Start Controlling Runaway Healthcare Costs. Jun 1, 2015 615
Eisai Receives European Commission Approval of Anticancer Agent Lenvima for Treatment of Advanced Thyroid Cancer Refractory to Radioactive Iodine. Jun 1, 2015 1209
More Americans support faster drug approval. Brief article Jun 1, 2015 226
Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis (carfilzomib) in Patients With Relapsed And Refractory Multiple Myeloma. May 31, 2015 3659
Ph no.:31205 knee caps xl size fda approved. May 30, 2015 127
The European Commission Approves ALOXI (palonosetron HCl) Injection to Prevent Nausea and Vomiting Due to Chemotherapy in Children as Young as One Month. May 27, 2015 868
The European Commission Approves ALOXI (palonosetron HCl) Injection to Prevent Nausea and Vomiting Due to Chemotherapy in Children as Young as One Month. May 27, 2015 873
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro, a DNA-Based Immunotherapeutic that Recently Received FDA Approval to Enter into Human Trials. May 27, 2015 1029
U.S. Food and Drug Administration Approves Humalog 200 units/mL KwikPen. May 27, 2015 2058
Cabinet approves drug rehabilitation programmes for addicts. May 27, 2015 235
Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults. May 27, 2015 1366
ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV. May 26, 2015 1912
FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD. May 26, 2015 3964
ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV. May 26, 2015 1907
First Drug to Treat Radiation Sickness Approved. May 25, 2015 684
New Research Leads to FDA Approval of First Drug to Treat Radiation Sickness. May 22, 2015 1173
(ph no.:42569) distal femoral condylar locking plate left and right sizes: 4,5,6,7,8 holes with required number of locking screws fda approved (each 02 nos). May 21, 2015 134
Final non-exclusive discount agreements pursuant to A* 130a paragraph 8 sgb v as part of the approval procedure for drug ustekinumab -. atc l04ac05 the period from 07.01.2015 to 06.30.2017 at the lates. May 20, 2015 128
Final non-exclusive discount agreements pursuant to A* 130a paragraph 8 sgb v as part of the approval procedure for drug roflumilast -. atc r03dx07 the period from 07.01.2015 to 06.30.2017 at the lates. May 20, 2015 127
U.S. FDA Approves INVEGA TRINZA(TM), First and Only Four-Times-A-Year Treatment for Schizophrenia. May 19, 2015 3755
Board-certified Plastic Surgeons Discuss Best Practices For Facial Rejuvenation At The Aesthetic Meeting Of The American Society For Aesthetic Plastic Surgery. May 16, 2015 1093
Final non-exclusive discount agreements pursuant to A* 130a paragraph 8 sgb v as part of the approval procedure for drug paliperidone -. atc n05ax13 in the period from 01.07.2015 to 30.06.2016 at the l. May 16, 2015 136
City chemists sell DUBIOUS medicines. May 16, 2015 500
Digital bp appartus 1. with puls and bp recording 2. capable of detecting irregular puls rate 3. capable of measuring puls and bp in inflationary cycle 4. should have us-fda approval 5. apparatus shou. May 14, 2015 130
New Jersey's First Reading Glasses Alternative! New FDA Approved KAMRA Inlay to Correct Presbyopia. May 13, 2015 311
Can-Fite's Phase II Liver Cancer Trial Approved in Europe. May 11, 2015 1050
Senate Approves Bill to Keep Execution Drug Providers Secret. May 11, 2015 491
CMC Biologics in Commercial Supply Agreement with Emergent BioSolutions for FDA-Approved IXINITY. May 5, 2015 568
CMC Biologics in Commercial Supply Agreement with Emergent BioSolutions for FDA-Approved IXINITY. May 5, 2015 595
PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients. May 4, 2015 612
FDA Approves Breakthrough Non-Surgical Treatment of Double Chin. May 1, 2015 619
FDA APPROVES NATPARA FOR INJECTION IN THE U.S. May 1, 2015 529
FDA CONFIRMS CHANGE OF OWNERSHIP OF GENERIC DRUGS. May 1, 2015 489
CLANOTECH RECEIVES ORPHAN DRUG DESIGNATION IN U.S. May 1, 2015 308
PRESCIENT THERAPEUTICS RECEIVES U.S. FDA APPROVAL. May 1, 2015 584
FDA panel: Alogliptin cardiovascular risk acceptable. Mechcatie, Elizabeth Clinical report May 1, 2015 683
FDA panel reassured by saxagliptin's CV safety data. Mechcatie, Elizabeth May 1, 2015 564
AMERIGEN Announces Tentative Approval of Generic Toviaz. Apr 30, 2015 392
FDA approves BREO ELLIPTA for the treatment of adults with asthma in the US. Apr 30, 2015 2948
Amgen Announces FDA Advisory Committee Meeting To Review Repatha(TM) (Evolocumab) As A Treatment For High Cholesterol. Apr 29, 2015 2068
The Multiple Sclerosis Association of America Publishes 2015 MS Research Update. Apr 29, 2015 708
Breckenridge Announces Approval for Repaglinide Tablets, USP. Apr 29, 2015 332
TWi Announces Settlement with Takeda on Dexilant(R) Litigation. Apr 27, 2015 614
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer. Apr 27, 2015 1155
Telesta Therapeutics Provides Key Corporate Updates. Apr 27, 2015 830
Astellas Launches CRESEMBA (isavuconazonium sulfate) in the United States for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis. Apr 27, 2015 1092
Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation. Apr 24, 2015 2018
Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation. Apr 24, 2015 2044
Assisi Animal Health Discusses FDA Approval of Cancer Treatments for Dogs. Apr 24, 2015 614
Lilly's CYRAMZA (ramucirumab) Receives Fourth FDA Approval. Apr 24, 2015 5025
Medicure Announces Approval of Expanded Dosing Time For AGGRASTAT[R]. Apr 23, 2015 1263
Orexigen Announces Receipt of Paragraph IV Certification Notice. Apr 22, 2015 2393
Final non-exclusive discount agreements pursuant to ? 130 abs 8 sgb v as part of the approval process for drug ustekinumab -. l04ac05 in the period from 01.05.2015 to 04.30.2017 at the latest. Apr 22, 2015 128
Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE. Apr 21, 2015 969
Process for drug tapentadol. Apr 21, 2015 135
Final non-exclusive discount agreements pursuant to A* 130 abs 8 sgb v as part of the approval process for drug goserelin -. atc l02ae03 in the period from 1.6.2015 to 31.05.2016 at the latest (excl. e. Apr 21, 2015 136
Final non-exclusive discount agreements pursuant to A* 130 abs 8 sgb v as part of the approval process for drug fulvestrant -. atc l02ba03 in the period from 1.6.2015 to 31.05.2017 at the latest. Apr 21, 2015 129
Actavis Announces FDA Approval of Expanded Label for BOTOX (OnabotulinumtoxinA) for the Treatment of Upper Limb Spasticity in Adults. Apr 20, 2015 2275
AMERIGEN Announces Tentative Approval of Generic Bystolic. Apr 17, 2015 427
Laser Locators Announces U.S. Launch of the FDA Approved LightMed TruScan577 - Those with Glaucoma and Retinal Diseases Stand to Benefit Most. Apr 16, 2015 492
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Orexigen Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 11, 2015 - OREX. Apr 15, 2015 501
FDA Approves Corlanor (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure. Apr 15, 2015 2840
Pharmaceutical Registration Strategies in Europe & the U.S. for Generics & Super Generics Course: London, UK - 7th, 8th of July 2015. Apr 15, 2015 491
Pharmaceutical Registration Strategies in Europe & the U.S. for Generics & Super Generics Course: London, UK - 7th, 8th of July 2015. Apr 15, 2015 497
Panel backs ICS/LABA combo for asthma in adults. Mechcatie, Elizabeth Apr 15, 2015 904
FDA approves Anthrasil to treat inhalational anthrax. Chitnis, Deepak Apr 15, 2015 303
C-FDA Approves IND for D-Pharm's Anti-Epileptic Drug, DP-VPA in China. Apr 14, 2015 537
FDA Advisory Committee Reviews Takeda's Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial. Apr 14, 2015 2992
FDA Advisory Committee Reviews Takeda's Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial. Apr 14, 2015 2963
Evaluation of d-glucose tracer fate analysis studies in hepatocytes of 26 fda approved tki inhibitor drugs. Apr 14, 2015 102
Depomed Announces Gralise ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal. Apr 13, 2015 742
Vanda Announces Trial Date for Fanapt Patent Cases. Apr 13, 2015 582
Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin. Apr 10, 2015 2504
Perrigo Announces FDA Approval and Upcoming Launch of the AB Therapeutic Equivalent to Exalgo. Apr 8, 2015 726
Mylan Launches First Generic Version of Generess Fe. Apr 7, 2015 488
FDA's Record Approvals Bode Well for PharmaCyte's Cancer Treatments. Apr 7, 2015 1052
New Cystic Fibrosis Treatments May Significantly Increase Pharmacy Benefit Costs. Apr 6, 2015 1107
New role for drug in battle against deadly eating disorder. Collier, Geraldine A. Apr 6, 2015 838
Hemlock large clips, hemlock large clips, us fda approved quality, each set having 14 strips of 6 clips each. Apr 6, 2015 253
Actavis Confirms Generic Letairis Patent Challenge. Apr 3, 2015 934
Swedish Match gears up for closely watched FDA panel meeting. Apr 2, 2015 236
Omeros Corporation Announces the U.S. Commercial Launch of Omidria(TM). Apr 2, 2015 1346
AbbVie's HUMIRA (Adalimumab) Approved by European Commission to Treat Children and Adolescents with Severe Chronic Plaque Psoriasis. Apr 1, 2015 1382
The FDA response: obstacles and delays. Shaath, Nadim Apr 1, 2015 1296
FDA APPROVES M-VU CAD FOR MAMMOGRAPHY VERSION 3.2. Apr 1, 2015 243
FDA APPROVES DEVELOPMENT OF INHALED NADOLOL. Apr 1, 2015 436
Unregulated menopause treatment use on the rise. Brunk, Doug Medical condition overview Apr 1, 2015 539
Asenapine OK'd for pediatric bipolar I. McKnight, Whitney Apr 1, 2015 235
Vaccine panel: replace two flu strains for 2015-2016. Mechcatie, Elizabeth Apr 1, 2015 632
MOVANTIK(TM) (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Launched In The US. Mar 31, 2015 1498
Mylan Launches Generic Exforge Tablets. Mar 31, 2015 437
Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015. Mar 31, 2015 492
FDA Grants Amgen Priority Review for Kyprolis (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma. Mar 30, 2015 2799
New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia. Mar 30, 2015 3316
New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia. Mar 29, 2015 3317
Final non-exclusive discount agreements pursuant to A* 130 abs 8 sgb v as part of the approval process for drug ustekinumab -. l04ac05 in the period from 01.05.2015 to 04.30.2017 at the latest. Mar 28, 2015 127
Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health. Mar 26, 2015 1048
EYLEA (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in Patients with Diabetic Macular Edema (DME). Mar 25, 2015 2313
AdverseEvents Sets New Standard For Drug Decision Making With Launch Of RxCost(TM). Mar 24, 2015 751
Health Ministry forms national database on pharmaceutical drugs. Mar 20, 2015 265
State Council Approves Amendments to Drugs, Psychotropic Substances Law. Mar 18, 2015 150
ASBM Educates Pharmacists on Biosimilars as FDA Makes First Approval. Mar 16, 2015 674
Actavis Receives FDA Approval for VIIBRYD (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose. Mar 16, 2015 2157
Pharmaceutical products. Mar 14, 2015 106
Actavis Receives FDA Approval of SAPHRIS for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder. Mar 13, 2015 2161
Blood cancer drug to be available on NHS. Mar 12, 2015 211
Endure Desensitizing Sexual Enhancement Spray Is FDA Approved. Mar 12, 2015 504
Mylan Launches Generic Antabuse Tablets. Mar 11, 2015 469
Mylan Launches Generic Subutex Sublingual Tablets. Mar 11, 2015 367
Neuroblastoma Expert John Maris, M.D., Available to Discuss FDA Approval of Unituxin, the Third FDA-Approved Drug Ever for Children with Cancer. Mar 11, 2015 394
NewSkin Laser Center Offering Restylane[R] Silk - First and Only FDA Approved Filler Indicated for Lip Enhancement and Treatment of Perioral Lines. Mar 10, 2015 348
Diclegis for Morning Sickness Now Available Through Aetna's National Coverage Policy. Medical condition overview Mar 10, 2015 1433
FDA Approves Unituxin(TM) (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma. Mar 10, 2015 2472
United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin(TM) for Pediatric High-Risk Neuroblastoma. Mar 10, 2015 1780
United States : Astellas Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis. Mar 10, 2015 663
Legal-Bay Lawsuit Settlement Funding Reports Bayer and Johnson & Johnson to Pursue Further FDA Approvals for Xarelto while Cases against the Drug are Consolidated into Multidistrict Litigation. Mar 9, 2015 727
Endure Desensitizing Sexual Enhancement Spray Is FDA Approved. Mar 9, 2015 422
United States : FDA approves first type of new generic. Mar 9, 2015 106
United States : US FDA made fast clearance to the lung cancer drug of BMS. Mar 7, 2015 311
United States : FDA approves first biosimilar product Zarxio. Mar 7, 2015 410
United States : FDA approves new antifungal drug Cresemba. Mar 7, 2015 413
Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed. Mar 6, 2015 790
Astellas Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis. Mar 6, 2015 1524
United States : Elepsia XR Levetiracetam extended-release tablets gets nod from FDA. Mar 5, 2015 117
United States : FDA expands approved use of Opdivo to treat lung cancer. Mar 5, 2015 438
Veloxis Pharmaceuticals publishes Annual Report 2014. Mar 3, 2015 7079
Ireland,United States : USFDA approval for ACTAVIS and MEDICINES360 for pregnancy prevention drug Liletta. Mar 3, 2015 263
Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults. Mar 2, 2015 1150
Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults. Mar 2, 2015 1155
Actavis Receives Approval from the European Commission for XYDALBA(TM) (dalbavancin). Mar 2, 2015 1080
FDA commissioner Dr. Margaret Hamburg resigns. Mar 1, 2015 133
AbbVie's HUMIRA (Adalimumab) Receives Positive CHMP Opinion to Treat Children and Adolescents With Severe Chronic Plaque Psoriasis. Feb 27, 2015 1242
Ireland : ACTAVIS wants FDA approval to market generic ulcerative colitis drug. Feb 27, 2015 164
The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients. Feb 26, 2015 817
AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting. Feb 26, 2015 1951
United States : FDA approves new antibacterial drug Avycaz. Feb 26, 2015 426
Actavis Receives U.S. FDA Approval for AVYCAZ(TM) (CEFTAZIDIME-AVIBACTAM). Feb 25, 2015 2389
Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com. Feb 25, 2015 667
United States : FDA approves Farydak for treatment of multiple myeloma. Feb 24, 2015 450
Actavis Confirms Generic Uceris Patent Challenge. Feb 24, 2015 867
Novartis receives FDA approval of Farydak, the first HDAC inhibitor for patients with multiple myeloma. Feb 23, 2015 2732
Azzi: NSSF will only cover approved generic drugs. Feb 21, 2015 392
Actavis Receives Final Approval for Generic Version of Subutex. Feb 20, 2015 712
United States : US FDA extends approval on its multiple myeloma blockbuster REVLIMID. Feb 20, 2015 117
Flu Treatment Sponsored By DoD's Medical Countermeasure Systems Takes Major Step Forward In Clinical Trials. Feb 19, 2015 844
United States : EISAI INC secures FDA approval for its supplemental New Drug Application. Feb 16, 2015 172
Switzerland : Novartis heart failure medicine LCZ696 granted FDA priority review. Feb 14, 2015 406
United States : FDA approves Lenvima for a type of thyroid cancer. Feb 14, 2015 428
Supply of Pharmaceutical products. Feb 14, 2015 109
Supply of Pharmaceutical products. Feb 14, 2015 105
Eisai Announces FDA Approval of BANZEL (rufinamide) for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Pediatric Patients Ages 1-4. Feb 13, 2015 1318
FDA Approves Eisai's LENVIMA(TM) (lenvatinib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer. Feb 13, 2015 2610
Actavis Launches Generic Pulmicort RESPULES. Feb 13, 2015 773
Multimedia Assets Now Available: FDA Approves Eisai's LENVIMA(TM) (lenvatinib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer. Feb 13, 2015 2642
Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma. Feb 11, 2015 2024
Switzerland : FDA approves Roche's Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema. Feb 10, 2015 345
United States : FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema. Feb 10, 2015 476
CASI Pharmaceuticals Announces Receipt Of Final Minutes From FDA Meeting Regarding Clinical And Regulatory Path Of ENMD-2076 For The Treatment Of Patients With Fibrolamellar Carcinoma (FLC). Feb 9, 2015 1314
European Commission Approves Additional Indication for VELCADE (bortezomib) in Mantle Cell Lymphoma. Feb 6, 2015 2033
New FDA Approved Filler Restylane Silk Available at Dr. Anne White's Cosmetic Surgery practice Carolina Laser and Cosmetic Center in Winston Salem. Feb 5, 2015 568
Anti-Epilepsy Drug Preserves Brain Function after Stroke. Feb 5, 2015 692
Germany,United States : FDA approves AESICA for German bulk manufacture and packaging sites. Feb 4, 2015 161
Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment of Acute Myelocytic Leukemia. Feb 4, 2015 756
THC and Opiates: "Entourage Effect" of Prismic's IP-Protected Palmitoylethanolamide Drives New Prescription Drug Strategy. Feb 3, 2015 469
Switzerland : Alcon receives FDA approval of Pazeo(TM) Solution for ocular allergy itch relief. Feb 3, 2015 416
Theravance Biopharma, Inc. and Mylan Partner to Develop and Commercialize a Novel LAMA Compound, TD-4208, for COPD. Feb 2, 2015 2514
Lpath Submits Investigational New Drug Application for Lpathomab for Neuropathic Pain. Feb 2, 2015 848
U.S. FDA approves first-in-class Glyxambi (empagliflozin/linagliptin) tablets for adults with type 2 diabetes. Feb 2, 2015 3117
FDA Approves New Dosing Option for CSL Behring's Hizentra. Feb 2, 2015 1382
TOS: FDA Approves New Drug for Binge Eating Disorder (BED). Feb 2, 2015 588
CM-24 RECEIVES FDA APPROVAL FOR PHASE 1 TRIAL. Feb 1, 2015 516
New law to expedite sunscreen approvals. Krisberg, Kim Feb 1, 2015 147
PL DEVELOPMENTS RECEIVES ITS FIRST ANDA APPROVAL. Feb 1, 2015 211
FDA panel rejects oral desmopressin for nocturia. Mechcatie, Elizabeth Feb 1, 2015 977
FDA approves IV antibacterial for complicated UTIs. Mechcatie, Elizabeth Feb 1, 2015 319
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia. Jan 30, 2015 606
Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder. Jan 30, 2015 2555
Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder. Jan 30, 2015 2560
United States : U.S. FDA Approves IMBRUVICA(ibrutinib) for the Treatment of Waldenstrom's Macroglobulinemia: First FDA-Approved Therapy for This Disease. Jan 30, 2015 450
United States : FDA expands approved use of Imbruvica for rare form of non-Hodgkin lymphoma. Jan 30, 2015 432
Galderma Launches Restylane Silk - First and Only FDA Approved Filler Indicated for Lip Enhancement and Treatment of Perioral Lines. Jan 29, 2015 1434
U.S. FDA Approves IMBRUVICA (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia (WM). Jan 29, 2015 2959
U.S. FDA Approves IMBRUVICA (ibrutinib) for the Treatment of Waldenstrom's Macroglobulinemia: First FDA-Approved Therapy for This Disease. Jan 29, 2015 2263
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia. Jan 29, 2015 604
Sweden,United States : FDA approves new strength of Norditropin FlexPro. Jan 29, 2015 151
PMC Analysis: More Than 20 Percent of FDA's 2014 Novel New Drug Approvals are Personalized Medicines. Jan 28, 2015 544
RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S. Jan 28, 2015 1031
Amgen Submits Applications In The US And Europe For Kyprolis (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma. Jan 27, 2015 2949
United States : BEXSERO VACCINE gets approval from FDA. Jan 27, 2015 102
Impax Receives FDA Approval for a Generic Version of Lamictal Orally Disintegrating Tablets (ODT). Jan 26, 2015 1249
Weight-loss shortcuts: The truth behind the hype. Jan 25, 2015 641
Switzerland : Novartis Bexsero vaccine approved by FDA for the prevention of meningitis B, the leading cause of bacterial meningitis in the US. Jan 24, 2015 432

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters